_id
691b08863c536f8df231896e
Ticker
ALAFY.PA
Name
Afyren SAS
Exchange
PA
Address
9-11 rue Gutenberg, Clermont-Ferrand, France, 63100
Country
France
Sector
Basic Materials
Industry
Specialty Chemicals
Currency
EUR
Website
https://afyren.com
Description
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.
Last Close
2.815
Volume
4327
Current Price
2.87
Change
-0.17761989342806014
Last Updated
2025-12-30T12:33:16.358Z
Image
https://logo.clearbit.com/afyren.com
Ipo Date
-
Market Cap
99832128
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.996
Sentiment Sources
1
Rating
4
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1204000
Cost Of Revenue
1390000
Gross Profit
-186000
Operating Expenses
3455000
Operating Income
-3641000
Interest Expense
41000
Pretax Income
-6924000
Net Income
-6924000
Eps
-0.2700000046793762
Dividends Per Share
-
Shares Outstanding
35527449
Income Tax Expense
-
EBITDA
-3217000
Operating Margin
-302.4086378737541
Total Other Income Expense Net
-3283000
Cash
27468000
Short Term Investments
154000
Receivables
513000
Inventories
-
Total Current Assets
42124000
Property Plant Equipment
532000
Total Assets
51458000
Payables
253000
Short Term Debt
1205000
Long Term Debt
1382000
Total Liabilities
5302000
Equity
46156000
Bs_currency_symbol
EUR
Depreciation
424000
Change In Working Capital
196000
Cash From Operations
-2353000
Capital Expenditures
84000
Cash From Investing
-3026000
Cash From Financing
-691000
Net Change In Cash
-6069999
Cf_currency_symbol
-
PE
-
PB
1.5945825955455413
ROE
-15.001299939336166
ROA
-13.455633720704263
FCF
-2437000
Fcf Percent
-2.0240863787375414
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1204000
Quarters > 0 > income Statement > cost Of Revenue
1390000
Quarters > 0 > income Statement > gross Profit
-186000
Quarters > 0 > income Statement > operating Expenses
3455000
Quarters > 0 > income Statement > operating Income
-3641000
Quarters > 0 > income Statement > interest Expense
41000
Quarters > 0 > income Statement > pretax Income
-6924000
Quarters > 0 > income Statement > net Income
-6924000
Quarters > 0 > income Statement > eps
-0.2700000046793762
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
25644444
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3217000
Quarters > 0 > income Statement > operating Margin
-302.4086378737541
Quarters > 0 > income Statement > total Other Income Expense Net
-3283000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
27468000
Quarters > 0 > balance Sheet > short Term Investments
154000
Quarters > 0 > balance Sheet > receivables
513000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
42124000
Quarters > 0 > balance Sheet > property Plant Equipment
532000
Quarters > 0 > balance Sheet > total Assets
51458000
Quarters > 0 > balance Sheet > payables
253000
Quarters > 0 > balance Sheet > short Term Debt
1205000
Quarters > 0 > balance Sheet > long Term Debt
1382000
Quarters > 0 > balance Sheet > total Liabilities
5302000
Quarters > 0 > balance Sheet > equity
46156000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-6924000
Quarters > 0 > cash Flow > depreciation
424000
Quarters > 0 > cash Flow > change In Working Capital
196000
Quarters > 0 > cash Flow > cash From Operations
-2353000
Quarters > 0 > cash Flow > capital Expenditures
84000
Quarters > 0 > cash Flow > cash From Investing
-3026000
Quarters > 0 > cash Flow > cash From Financing
-691000
Quarters > 0 > cash Flow > net Change In Cash
-6069999
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.2700000046793762
Quarters > 0 > ratios > PB
1.5945825955455413
Quarters > 0 > ratios > ROE
-15.001299939336166
Quarters > 0 > ratios > ROA
-13.455633720704263
Quarters > 0 > ratios > FCF
-2437000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.0240863787375414
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1498000
Quarters > 1 > income Statement > cost Of Revenue
3141000
Quarters > 1 > income Statement > gross Profit
-1643000
Quarters > 1 > income Statement > operating Expenses
1271000
Quarters > 1 > income Statement > operating Income
-2914000
Quarters > 1 > income Statement > interest Expense
46000
Quarters > 1 > income Statement > pretax Income
-4432000
Quarters > 1 > income Statement > net Income
-4432000
Quarters > 1 > income Statement > eps
-0.1712325723915449
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
25882926
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1083000
Quarters > 1 > income Statement > operating Margin
-194.5260347129506
Quarters > 1 > income Statement > total Other Income Expense Net
-1518000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
33538000
Quarters > 1 > balance Sheet > short Term Investments
107000
Quarters > 1 > balance Sheet > receivables
432000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
45106000
Quarters > 1 > balance Sheet > property Plant Equipment
500000
Quarters > 1 > balance Sheet > total Assets
58560000
Quarters > 1 > balance Sheet > payables
526000
Quarters > 1 > balance Sheet > short Term Debt
1281000
Quarters > 1 > balance Sheet > long Term Debt
1972000
Quarters > 1 > balance Sheet > total Liabilities
5862000
Quarters > 1 > balance Sheet > equity
52698000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-4432000
Quarters > 1 > cash Flow > depreciation
446000
Quarters > 1 > cash Flow > change In Working Capital
-570000
Quarters > 1 > cash Flow > cash From Operations
-1687000
Quarters > 1 > cash Flow > capital Expenditures
150000
Quarters > 1 > cash Flow > cash From Investing
-7987000
Quarters > 1 > cash Flow > cash From Financing
-190000
Quarters > 1 > cash Flow > net Change In Cash
-9864000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.1712325723915449
Quarters > 1 > ratios > PB
1.4096170181031538
Quarters > 1 > ratios > ROE
-8.410186344832821
Quarters > 1 > ratios > ROA
-7.5683060109289615
Quarters > 1 > ratios > FCF
-1837000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.22630173564753
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1364000
Quarters > 2 > income Statement > cost Of Revenue
3929000
Quarters > 2 > income Statement > gross Profit
-2565000
Quarters > 2 > income Statement > operating Expenses
1268000
Quarters > 2 > income Statement > operating Income
-3833000
Quarters > 2 > income Statement > interest Expense
48000
Quarters > 2 > income Statement > pretax Income
-5322000
Quarters > 2 > income Statement > net Income
-5322000
Quarters > 2 > income Statement > eps
-0.20433444734385375
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
26045535
Quarters > 2 > income Statement > income Tax Expense
3978000
Quarters > 2 > income Statement > EBITDA
-2160000
Quarters > 2 > income Statement > operating Margin
-281.0117302052786
Quarters > 2 > income Statement > total Other Income Expense Net
-1489000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
43402000
Quarters > 2 > balance Sheet > short Term Investments
100000
Quarters > 2 > balance Sheet > receivables
1118000
Quarters > 2 > balance Sheet > inventories
82000
Quarters > 2 > balance Sheet > total Current Assets
47246000
Quarters > 2 > balance Sheet > property Plant Equipment
613000
Quarters > 2 > balance Sheet > total Assets
63917000
Quarters > 2 > balance Sheet > payables
282000
Quarters > 2 > balance Sheet > short Term Debt
1584000
Quarters > 2 > balance Sheet > long Term Debt
2269000
Quarters > 2 > balance Sheet > total Liabilities
7184000
Quarters > 2 > balance Sheet > equity
56733000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-5322000
Quarters > 2 > cash Flow > depreciation
405000
Quarters > 2 > cash Flow > change In Working Capital
-635000
Quarters > 2 > cash Flow > cash From Operations
-2583000
Quarters > 2 > cash Flow > capital Expenditures
71000
Quarters > 2 > cash Flow > cash From Investing
-2573000
Quarters > 2 > cash Flow > cash From Financing
-1001000
Quarters > 2 > cash Flow > net Change In Cash
-6157000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.20433444734385375
Quarters > 2 > ratios > PB
1.317587390936492
Quarters > 2 > ratios > ROE
-9.380783670879381
Quarters > 2 > ratios > ROA
-8.326423330256425
Quarters > 2 > ratios > FCF
-2654000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.9457478005865103
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
1424000
Quarters > 3 > income Statement > cost Of Revenue
1693000
Quarters > 3 > income Statement > gross Profit
-269000
Quarters > 3 > income Statement > operating Expenses
4851000
Quarters > 3 > income Statement > operating Income
-3131000
Quarters > 3 > income Statement > interest Expense
306000
Quarters > 3 > income Statement > pretax Income
-4463000
Quarters > 3 > income Statement > net Income
-4463000
Quarters > 3 > income Statement > eps
-0.17169968997106844
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
25993058
Quarters > 3 > income Statement > income Tax Expense
4542000
Quarters > 3 > income Statement > EBITDA
-6548000
Quarters > 3 > income Statement > operating Margin
-219.87359550561797
Quarters > 3 > income Statement > total Other Income Expense Net
-1332000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
49559000
Quarters > 3 > balance Sheet > short Term Investments
99000
Quarters > 3 > balance Sheet > receivables
601000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
50948000
Quarters > 3 > balance Sheet > property Plant Equipment
779000
Quarters > 3 > balance Sheet > total Assets
70427000
Quarters > 3 > balance Sheet > payables
388000
Quarters > 3 > balance Sheet > short Term Debt
1610000
Quarters > 3 > balance Sheet > long Term Debt
2951000
Quarters > 3 > balance Sheet > total Liabilities
8628000
Quarters > 3 > balance Sheet > equity
61799000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-4463000
Quarters > 3 > cash Flow > depreciation
408000
Quarters > 3 > cash Flow > change In Working Capital
-948000
Quarters > 3 > cash Flow > cash From Operations
-2043000
Quarters > 3 > cash Flow > capital Expenditures
197000
Quarters > 3 > cash Flow > cash From Investing
-263000
Quarters > 3 > cash Flow > cash From Financing
-788000
Quarters > 3 > cash Flow > net Change In Cash
-3093000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.17169968997106844
Quarters > 3 > ratios > PB
1.2071405113351348
Quarters > 3 > ratios > ROE
-7.221799705496852
Quarters > 3 > ratios > ROA
-6.337058230508186
Quarters > 3 > ratios > FCF
-2240000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.5730337078651686
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2862000
Annuals > 0 > income Statement > cost Of Revenue
3036000
Annuals > 0 > income Statement > gross Profit
-174000
Annuals > 0 > income Statement > operating Expenses
5904000
Annuals > 0 > income Statement > operating Income
-6078000
Annuals > 0 > income Statement > interest Expense
94000
Annuals > 0 > income Statement > pretax Income
-9754000
Annuals > 0 > income Statement > net Income
-9754000
Annuals > 0 > income Statement > eps
-0.3744979705734591
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
26045535
Annuals > 0 > income Statement > income Tax Expense
-5567000
Annuals > 0 > income Statement > EBITDA
-8808000
Annuals > 0 > income Statement > operating Margin
-212.36897274633125
Annuals > 0 > income Statement > total Other Income Expense Net
-3676000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
33538000
Annuals > 0 > balance Sheet > short Term Investments
107000
Annuals > 0 > balance Sheet > receivables
432000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
45106000
Annuals > 0 > balance Sheet > property Plant Equipment
500000
Annuals > 0 > balance Sheet > total Assets
58560000
Annuals > 0 > balance Sheet > payables
526000
Annuals > 0 > balance Sheet > short Term Debt
1281000
Annuals > 0 > balance Sheet > long Term Debt
1972000
Annuals > 0 > balance Sheet > total Liabilities
5862000
Annuals > 0 > balance Sheet > equity
52698000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-9754000
Annuals > 0 > cash Flow > depreciation
851000
Annuals > 0 > cash Flow > change In Working Capital
-1205000
Annuals > 0 > cash Flow > cash From Operations
-5623000
Annuals > 0 > cash Flow > capital Expenditures
221000
Annuals > 0 > cash Flow > cash From Investing
-9114000
Annuals > 0 > cash Flow > cash From Financing
-1284000
Annuals > 0 > cash Flow > net Change In Cash
-16021000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.3744979705734591
Annuals > 0 > ratios > PB
1.3937608391210292
Annuals > 0 > ratios > ROE
-18.50924133743216
Annuals > 0 > ratios > ROA
-16.65642076502732
Annuals > 0 > ratios > FCF
-5844000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.041928721174004
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3379000
Annuals > 1 > income Statement > cost Of Revenue
3091000
Annuals > 1 > income Statement > gross Profit
645000
Annuals > 1 > income Statement > operating Expenses
6573000
Annuals > 1 > income Statement > operating Income
-5928000
Annuals > 1 > income Statement > interest Expense
180000
Annuals > 1 > income Statement > pretax Income
-9586000
Annuals > 1 > income Statement > net Income
-9586000
Annuals > 1 > income Statement > eps
-0.36952772460200406
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
25941220
Annuals > 1 > income Statement > income Tax Expense
4800000
Annuals > 1 > income Statement > EBITDA
-8592000
Annuals > 1 > income Statement > operating Margin
-175.4365196803788
Annuals > 1 > income Statement > total Other Income Expense Net
-3658000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
49559000
Annuals > 1 > balance Sheet > short Term Investments
99000
Annuals > 1 > balance Sheet > receivables
466000
Annuals > 1 > balance Sheet > inventories
-76000
Annuals > 1 > balance Sheet > total Current Assets
50948000
Annuals > 1 > balance Sheet > property Plant Equipment
779000
Annuals > 1 > balance Sheet > total Assets
70427000
Annuals > 1 > balance Sheet > payables
388000
Annuals > 1 > balance Sheet > short Term Debt
1610000
Annuals > 1 > balance Sheet > long Term Debt
2951000
Annuals > 1 > balance Sheet > total Liabilities
8628000
Annuals > 1 > balance Sheet > equity
61799000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-9586000
Annuals > 1 > cash Flow > depreciation
814000
Annuals > 1 > cash Flow > change In Working Capital
-1206000
Annuals > 1 > cash Flow > cash From Operations
-5041000
Annuals > 1 > cash Flow > capital Expenditures
559000
Annuals > 1 > cash Flow > cash From Investing
-3078000
Annuals > 1 > cash Flow > cash From Financing
-4655000
Annuals > 1 > cash Flow > net Change In Cash
-12774000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.36952772460200406
Annuals > 1 > ratios > PB
1.183744727260959
Annuals > 1 > ratios > ROE
-15.51157785724688
Annuals > 1 > ratios > ROA
-13.611257046303265
Annuals > 1 > ratios > FCF
-5600000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.6572950577093815
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3456000
Annuals > 2 > income Statement > cost Of Revenue
2396000
Annuals > 2 > income Statement > gross Profit
1060000
Annuals > 2 > income Statement > operating Expenses
6431000
Annuals > 2 > income Statement > operating Income
-5371000
Annuals > 2 > income Statement > interest Expense
199000
Annuals > 2 > income Statement > pretax Income
-9200000
Annuals > 2 > income Statement > net Income
-9200000
Annuals > 2 > income Statement > eps
-0.35701770691407475
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25769030
Annuals > 2 > income Statement > income Tax Expense
-3695000
Annuals > 2 > income Statement > EBITDA
-4710000
Annuals > 2 > income Statement > operating Margin
-155.41087962962962
Annuals > 2 > income Statement > total Other Income Expense Net
-3829000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
62332000
Annuals > 2 > balance Sheet > short Term Investments
71000
Annuals > 2 > balance Sheet > receivables
884000
Annuals > 2 > balance Sheet > inventories
456000
Annuals > 2 > balance Sheet > total Current Assets
63822000
Annuals > 2 > balance Sheet > property Plant Equipment
803000
Annuals > 2 > balance Sheet > total Assets
84821000
Annuals > 2 > balance Sheet > payables
520000
Annuals > 2 > balance Sheet > short Term Debt
5054000
Annuals > 2 > balance Sheet > long Term Debt
3261000
Annuals > 2 > balance Sheet > total Liabilities
13844000
Annuals > 2 > balance Sheet > equity
70977000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-9200000
Annuals > 2 > cash Flow > depreciation
629000
Annuals > 2 > cash Flow > change In Working Capital
-973000
Annuals > 2 > cash Flow > cash From Operations
-3296000
Annuals > 2 > cash Flow > capital Expenditures
531000
Annuals > 2 > cash Flow > cash From Investing
-362000
Annuals > 2 > cash Flow > cash From Financing
-1138000
Annuals > 2 > cash Flow > net Change In Cash
-4795000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.35701770691407475
Annuals > 2 > ratios > PB
1.0238339828395113
Annuals > 2 > ratios > ROE
-12.961945418938528
Annuals > 2 > ratios > ROA
-10.846370592188254
Annuals > 2 > ratios > FCF
-3827000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.107349537037037
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3036000
Annuals > 3 > income Statement > cost Of Revenue
1564000
Annuals > 3 > income Statement > gross Profit
1472000
Annuals > 3 > income Statement > operating Expenses
3648000
Annuals > 3 > income Statement > operating Income
-2176000
Annuals > 3 > income Statement > interest Expense
216000
Annuals > 3 > income Statement > pretax Income
-3608000
Annuals > 3 > income Statement > net Income
-3609000
Annuals > 3 > income Statement > eps
-0.14008992461151346
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25762024
Annuals > 3 > income Statement > income Tax Expense
1000
Annuals > 3 > income Statement > EBITDA
-2780000
Annuals > 3 > income Statement > operating Margin
-71.67325428194994
Annuals > 3 > income Statement > total Other Income Expense Net
-1433000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
67128000
Annuals > 3 > balance Sheet > short Term Investments
230000
Annuals > 3 > balance Sheet > receivables
1096000
Annuals > 3 > balance Sheet > inventories
302000
Annuals > 3 > balance Sheet > total Current Assets
68903000
Annuals > 3 > balance Sheet > property Plant Equipment
284000
Annuals > 3 > balance Sheet > total Assets
93149000
Annuals > 3 > balance Sheet > payables
513000
Annuals > 3 > balance Sheet > short Term Debt
950000
Annuals > 3 > balance Sheet > long Term Debt
7957000
Annuals > 3 > balance Sheet > total Liabilities
15293000
Annuals > 3 > balance Sheet > equity
77856000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-3609000
Annuals > 3 > cash Flow > depreciation
612000
Annuals > 3 > cash Flow > change In Working Capital
-1394000
Annuals > 3 > cash Flow > cash From Operations
-2715000
Annuals > 3 > cash Flow > capital Expenditures
345000
Annuals > 3 > cash Flow > cash From Investing
-436000
Annuals > 3 > cash Flow > cash From Financing
60770000
Annuals > 3 > cash Flow > net Change In Cash
57620000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.14008992461151346
Annuals > 3 > ratios > PB
0.9331189334155364
Annuals > 3 > ratios > ROE
-4.635480887792848
Annuals > 3 > ratios > ROA
-3.8744377288000944
Annuals > 3 > ratios > FCF
-3060000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.007905138339921
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2700000046793762
Valuation > metrics > PB
1.5945825955455413
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-15.001299939336166
Profitability > metrics > ROA
-16.43718545247365
Profitability > metrics > Net Margin
-5.750830564784053
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11487130600571974
Risk > metrics > Interest Coverage
-88.8048780487805
Risk > final Score
-295
Risk > verdict
High
Liquidity > metrics > Current Ratio
28.891632373113854
Liquidity > metrics > Quick Ratio
28.891632373113854
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-193
Prev Risks > 1
-259
Prev Risks > 2
19
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:08:28.819Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.27
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.27
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-28
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.17
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.17
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-21
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.36
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.36
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-27
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.16
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.16
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-04-14
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.15
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.15
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-14
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.03
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.03
Earnings History > 6 > surprise Percent
-
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AForFarmers And 2 Other European Penny Stocks To Watch Closely Yahoo Finance
Read more →European Market Insights: AFYREN SAS And 2 Other Noteworthy Penny Stocks Yahoo Finance
Read more →Showing 2 of 5
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Afyren SAS
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.27
EPS Estimate
0
EPS Difference
-0.27
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.